Trial
NCT05876572
Blood Naloxone Levels Following Intradermal Injection in Humans
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
DEKA S.r.l.
Condition
Opioid Overdose
Intervention
intradermal naloxone
Why stopped
Currently does not have active IRB status
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-01